LDS has attended the last edition of Meet in Italy for Life Sciences which is the main national matchmaking and update event on topical issues in Life Sciences
LDS was present at the two working days of the MIT4LS, which was held in Turin from 11th to 12th October, as a great opportunity for business meetings, networking activities, and to be updated about industry’s key trends and innovation strategies. LDS participated to several bilateral face to face meetings with potential collaboration partners for science and business from several countries all over Europe and also outside.
MIT4LS was organised by Confindustria Piemonte, Piemonte Innnovation Cluster BioPmed, Life Sciences Technological Cluster Alisei, and Camera di Commercio di Torino and involved more than 400 participants from 36 countries with the aim to highlight innovative startup in the Life Sciences sector and facilitate new collaborations and business.
Lead Discovery Siena is Sponsor of the 11th EWDD. The workshop will be held in Certosa di Pontignano at the Conference Center of the University of Siena.
First in this kind, the European Workshop in Drug Design has always been a unique opportunity for graduate students, postdocs and scientists from both Academia and Pharma Industry to celebrate computer-aided drug design and discovery in an exciting and collaborative environment, looking at an impressive sight of the city of Siena from a monastic complex in the heart of the Chianti and Tuscany, and participating to highly interactive hands-on case studies.
LDS is pleased to support this workshop which offers an updated view on most recent modelling techniques and approaches together with the opportunity to meet representatives from both university and pharma industries. LDS will be present during the event and available to talk about the available range of research services and its drug discovery programmes.
On May 21-26, 2017
LDS has participated to the Toscana Life Sciences Day 2016, the annual event organized by the Foundation to promote the exchange and contamination of ideas, foster mutual knowledge and the confrontation among the companies and research groups hosted by TLS.
LDS gave a presentation to show its corporate and research activities, competences and platforms, to keep updated the other companies working in the Life Science area and identify potential common interests. It has been a great opportunity to strengthen the existing relationships and to build new potential collaborations with the several differing realities relating to TLS, from biotech to medical devices, medicinal chemistry, ICT, research services and nutraceutics.
Twenty companies participated to the event together with LDS, such as Pharma Integration, Liquidweb, T4All, egoHealth, Microbiotec, Exosomics Siena, CNR – IFC Siena, Fondazione NIBIT, Università di Siena – Dip. Scienze della Vita, Fondazione di Mario, Ebios Futura, TLS-Lab ERC, Kedrion, VisMederi, Bioscence Research Centre, Polo GGB, Epigen Therapeutics, Istituto Tumori Toscano, Università di Siena – Quantitative Neuroimaging Laboratory.
In this scenario, LDS is the only company working in the Medicinal Chemistry area by providing support to drug discovery projects.
At the end of the event, LDS Project Manager Laura Maccari gave an interview about the potential synergies of LDS with the other companies hosted by TLS.
FULL TLS DAY PROGRAM
Smau is the matching platform for innovation and professional continuous training. For over 50 years, Smau supports Italian companies and professionals to innovate, and it is an opportunity for entrepreneurs, managers, companies, and public administrations to grow up and to catch up on innovation, technology, and ICT. Smau is a national event roadshow helping public actors and companies willing to look beyond the present and opportunities offered by new technologies, digital world, and most promising start ups.
The event of this year is also dedicated to the synergies among research centres, companies and public funding in the Life Sciences areas as experienced in Fas Salute 2014 Call of Tuscany Region which UNAVIR is belonging to.
UNAVIR is a project aimed at identifying new therapeutic treatments for rare viral infections, such as Dengue, Chikungunya and West Nile and brings together Universities of Siena, Pisa, and Florence and companies, Lead Discovery Siena and VisMederi, to develop innovative treatments of personalised medicine. LDS will contribute to the projects by supporting the design, synthesis and ADMET characterization of new molecular entities active against these virues.
Maurizio Botta, LDS CEO, was the rapporteur on this project at Smau Florence to show its background, the research strategy and its potentialities.